Registro de Citas
Cita APA (7a ed.)
Deng, L., Peng, Y., Tan, C., Yi, L., Wang, H., Yuan, D., & Wen, Z. (2026). Telitacicept versus belimumab for the treatment of systemic lupus erythematosus: A network meta-analysis and cost-effectiveness analysis. BMJ Publishing Group.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Deng, Li, Ye Peng, Chongqing Tan, Lidan Yi, Haihong Wang, Dou Yuan, y Zhenhua Wen. Telitacicept Versus Belimumab for the Treatment of Systemic Lupus Erythematosus: A Network Meta-analysis and Cost-effectiveness Analysis. BMJ Publishing Group, 2026.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Deng, Li, et al. Telitacicept Versus Belimumab for the Treatment of Systemic Lupus Erythematosus: A Network Meta-analysis and Cost-effectiveness Analysis. BMJ Publishing Group, 2026.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.
